All In Biotech

Drug Trial Radar · NCT05018286

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

158

Actual

Start

Jul 13, 2021

Primary completion

Oct 30, 2027

Study completion Oct 30, 2027

Sponsor

Lead sponsor
VectivBio AGIndustry
Sponsor type
Industry
First posted
Aug 24, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.

Conditions

  • Short Bowel Syndrome

Interventions

  • ApraglutideDrug

    Apraglutide is a synthetic peptide analogue of GLP-2 under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor with in vitro potency and selectivity comparable with native GLP-2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events (AE)Time frame: From baseline to week 208
  2. Clinical chemistryTime frame: From baseline to week 208
  3. HematologyTime frame: From baseline to week 208
  4. HemostasisTime frame: From baseline to week 104
  5. UrinalysisTime frame: From baseline to week 208
  6. Occurrence of clinically relevant changes in vital signsTime frame: From baseline to week 208
  7. Occurrence of clinically relevant changes in electrocardiogramTime frame: From baseline to week 208

Locations

66 sites in 18 countries. Site status is shown where the registry gives one.

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • Gastroenterology Group of Naples

    Naples, Florida

  • Northwestern University - Chicago

    Chicago, Illinois

  • Henry Ford Health System

    Detroit, Michigan

  • Mayo Clinic - Rochester

    Rochester, Minnesota

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Mount Sinai Medical Center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • University of Washington Medical Center

    Seattle, Washington

  • University Hospital Fundacion Favaloro

    Buenos Aires, Argentina

  • University Hospital Brussels

    Brussels, Belgium

  • UZ Leuven

    Leuven, Belgium

  • University Hospital Brno

    Brno, Czechia

  • University Hospital Hradec Kralove

    Hradec Králové, Czechia

  • Hospital Novy Jicin

    Nový Jičín, Czechia

  • University Hospital Plzen

    Pilsen, Czechia

  • University Hospital Kralovske Vinohrady

    Prague, Czechia

  • General University Hospital in Prague

    Prague, Czechia

  • Rigshospitalet - University Hospital Copenhagen, Department of Intestinal Failure and Liver Diseases

    Copenhagen, Denmark

  • Beaujon Hospital

    Clichy, France

  • South Lyon Hospital Center

    Lyon, France

  • Nantes University Hospital Center - Hotel Dieu Hospital

    Nantes, France

  • Nice University Hospital Center - Archet 1 Hospital

    Nice, France

  • Hôpital Haut-Lévèque

    Pessac, France

  • Brabois Adults Hospital

    Vandœuvre-lès-Nancy, France

  • Charite - University Hospital Berlin

    Berlin, Germany

  • University Hospital Bonn

    Bonn, Germany

  • Asklepios Clinic St. Georg

    Hamburg, Germany

  • University Hospital Heidelberg

    Heidelberg, Germany

  • University Hospital Muenster

    Münster, Germany

  • Szent Imre University Teaching Hospital, Department of Gastroenterology

    Budapest, Hungary

  • Central Hospital of Northern Pest - Military Hospital

    Budapest, Hungary

  • Semmelweis University

    Budapest, Hungary

  • University of Szeged

    Szeged, Hungary

  • Rambam Health Care Campus, Institute of Gastroenterology

    Haifa, Israel

  • Chaim Sheba Medical Center

    Tel HaShomer, Israel

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.